Germany
· Delayed Price · Currency is EUR BioPharma Credit Statistics
Total Valuation
MUN:B3P has a market cap or net worth of EUR 898.03 million. The enterprise value is 887.28 million.
| Market Cap | 898.03M |
| Enterprise Value | 887.28M |
Important Dates
The last earnings date was Tuesday, March 24, 2026.
| Earnings Date | Mar 24, 2026 |
| Ex-Dividend Date | Feb 19, 2026 |
Share Statistics
| Current Share Class | 1.13B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -6.77% |
| Shares Change (QoQ) | -1.83% |
| Owned by Insiders (%) | 0.06% |
| Owned by Institutions (%) | 89.39% |
| Float | 1.06B |
Valuation Ratios
The trailing PE ratio is 8.12.
| PE Ratio | 8.12 |
| Forward PE | n/a |
| PS Ratio | 6.68 |
| PB Ratio | 0.92 |
| P/TBV Ratio | 0.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 11.57 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 8.02 |
| EV / Sales | 6.59 |
| EV / EBITDA | n/a |
| EV / EBIT | 8.00 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.77
| Current Ratio | 3.77 |
| Quick Ratio | 3.77 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 11.14% and return on invested capital (ROIC) is 6.96%.
| Return on Equity (ROE) | 11.14% |
| Return on Assets (ROA) | 6.85% |
| Return on Invested Capital (ROIC) | 6.96% |
| Return on Capital Employed (ROCE) | 11.28% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 3,285 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MUN:B3P had revenue of EUR 134.35 million and earned 110.62 million in profits. Earnings per share was 0.10.
| Revenue | 134.35M |
| Gross Profit | 134.35M |
| Operating Income | 110.59M |
| Pretax Income | 110.62M |
| Net Income | 110.62M |
| EBITDA | n/a |
| EBIT | 110.59M |
| Earnings Per Share (EPS) | 0.10 |
Balance Sheet
The company has 10.72 million in cash and n/a in debt, giving a net cash position of 10.72 million.
| Cash & Cash Equivalents | 10.72M |
| Total Debt | n/a |
| Net Cash | 10.72M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 980.19M |
| Book Value Per Share | 0.87 |
| Working Capital | 41.42M |
Cash Flow
| Operating Cash Flow | 77.59M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 82.32% and 82.34%.
| Gross Margin | 100.00% |
| Operating Margin | 82.32% |
| Pretax Margin | 82.34% |
| Profit Margin | 82.34% |
| EBITDA Margin | n/a |
| EBIT Margin | 82.32% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 8.78%.
| Dividend Per Share | 0.07 |
| Dividend Yield | 8.78% |
| Dividend Growth (YoY) | -25.81% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 61.56% |
| Buyback Yield | 6.77% |
| Shareholder Yield | 15.55% |
| Earnings Yield | 12.32% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MUN:B3P has an Altman Z-Score of 35.6 and a Piotroski F-Score of 4.
| Altman Z-Score | 35.6 |
| Piotroski F-Score | 4 |